$GTHX G1 Therapeutics, Inc. Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading in G1 Therapeutics, Inc..

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview


Overview of insider trading in G1 Therapeutics, Inc.. Insider overview, share value development, latest insider transactions and email notifications about new events in G1 Therapeutics, Inc. for free.

CIK Number: 0001560241
IRS Number: 263648180
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Trading Symbol: GTHX
Company Address: 700 PARK OFFICES DRIVE SUITE 200 RESEARCH TRIANGLE PARK 27709
Phone number: 919-213-9835
Former name: G-Zero Therapeutics, Inc., date of change: 2012-10-12

G1 Therapeutics, Inc. engages in the development of small molecule therapeutics for the treatment of patients with cancer. Its products pipeline includes trilaciclib, rintodestrant, and lerociclib. The company was founded by Kwok-Kin Wong and Norman E. Sharpless on May 19, 2008 and is headquartered in Research Triangle Park, NC.

G1 Therapeutics, Inc. Latest Insider Transactions

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
May 13 2021GTHXG1 Therapeutics, I ...Velleca Mark A.Option ExerciseM0.3910,0003,900307,286
May 13 2021GTHXG1 Therapeutics, I ...Velleca Mark A.Option ExerciseM0.3910,0003,900307,286
May 13 2021GTHXG1 Therapeutics, I ...Velleca Mark A.Option ExerciseM0.3910,0003,900317,286
May 13 2021GTHXG1 Therapeutics, I ...Velleca Mark A.Option ExerciseM0.3910,0003,900317,286
May 13 2021GTHXG1 Therapeutics, I ...Velleca Mark A.Option ExerciseM0.3910,0003,900327,286
May 13 2021GTHXG1 Therapeutics, I ...Velleca Mark A.Option ExerciseM0.3910,0003,900327,286
May 13 2021GTHXG1 Therapeutics, I ...Velleca Mark A.SellS20.5410,000205,41341,00051 K to 41 K (-19.61 %)
May 13 2021GTHXG1 Therapeutics, I ...Velleca Mark A.SellS20.5410,000205,41341,00051 K to 41 K (-19.61 %)
May 13 2021GTHXG1 Therapeutics, I ...Velleca Mark A.BuyM0.3910,0003,90051,00041 K to 51 K (+24.39 %)
May 13 2021GTHXG1 Therapeutics, I ...Velleca Mark A.BuyM0.3910,0003,90051,00041 K to 51 K (+24.39 %)
May 13 2021GTHXG1 Therapeutics, I ...Velleca Mark A.SellS20.0710,000200,69141,00051 K to 41 K (-19.61 %)
May 13 2021GTHXG1 Therapeutics, I ...Velleca Mark A.SellS20.0710,000200,69141,00051 K to 41 K (-19.61 %)
May 13 2021GTHXG1 Therapeutics, I ...Velleca Mark A.BuyM0.3910,0003,90051,00041 K to 51 K (+24.39 %)
May 13 2021GTHXG1 Therapeutics, I ...Velleca Mark A.BuyM0.3910,0003,90051,00041 K to 51 K (+24.39 %)
May 13 2021GTHXG1 Therapeutics, I ...Velleca Mark A.SellS19.1010,000190,99741,00051 K to 41 K (-19.61 %)

View all G1 Therapeutics, Inc. insider transactions.